Day One, November 20, 2024 - ET (Eastern Time, GMT-05:00)
Day One, November 20, 2024 - ET (Eastern Time, GMT-05:00)
- Callie Mertel - Conference Producer, Informa Connect
- Jeff Park - Senior Director, Patient Support Services, Cytokinetics
Is AI just hype or the key to unlocking the future of patient support? During this session, cut through the noise and strategize on the best practices in leveraging AI.
- Personalize the patient journey at scale for improved engagement and adherence
- Predict and proactively address patient needs through data-driven insights
- Optimize resource allocation and streamline program operations
- Drive innovation in patient support services and stay ahead of the curve
- Rebecca Cotton - Executive Director, Patient Services Innovation and Product Solutions, Cardinal Health Sonexus™ Access & Patient Support
- Chad Ramsey - Senior Director, Engineering, Cardinal Health Sonexus Access and Patient Support
This session delves into the latest trends and benchmarks in patient support models, providing a perspective of the benefits and challenges associated with each type. Attendees gain valuable insights into best practices for building, optimizing and seamlessly integrating their patient support models.
- Current trends and best practices in PSP operating models
- Evaluating operating models for benefits and challenges
- Assess strategic decisions for insourcing vs. outsourcing PSP components
- Leveraging specialized providers through enhanced PSP integration
- Josh Konetzni - Vice President, Head of Business Development, VMS BioMarketing
- Patrick Gomez Menzies - Director, Market Access, Chiesi USA, Inc.
- Geoff Fisher - Senior Manager, Patient Experience and Reimbursement, GSK
- Jenna Okoro - Director, Sales, Authenticx
- April Onufrak - Associated Director of Digital Solutions, Lilly Patient Services, Eli Lilly
- Geoff Fisher - Senior Manager, Patient Experience and Reimbursement, GSK
- Meghan Jones - Associate Director, Patient Support Services, Rare Blood Disorders, U.S. Sanofi Genzyme
As the patient support landscape continues to evolve so do the regulatory requirements and level of oversight around programs. Hear directly from enforcement agents regarding top trends, focal points and priorities for patient support programs in 2024 and beyond.
- Richard Liner - Senior Assistant General Counsel, Bayer
- Steven Sharobem - Assistant United States Attorney, US Attorney’s Office, District of Massachusetts
As the intricacies surrounding patient access become more complex, so have the compliance challenges faced by manufacturers.
- Discuss what is top of mind on compliance’s radar and why it should also be on yours
- Understand the importance of robust data and an effective vendor partnership in remaining compliant
- Learn the necessity behind compliance, marketing and commercial teams working together to conduct due diligence on your hub and the specific activities that are involved in doing so
- Navigate evolving regulations and enforcement activity with new patient access-related needs to mitigate risk and remain compliant
- Tara Kennedy - Global Director, Ethics & Compliance, Apellis Pharmaceuticals
- Donna White - Vice President, Compliance Officer, Chiesi USA Inc.
- Jonathan Amar - Assistant General Counsel, Sanofi
With field teams on the front lines, it is crucial for organizations to empower their FRMs and sales teams whilst also mitigating compliance risk.
- Uncover best practices in training and monitoring activities, including sensitivity training, whilst remaining compliant
- Discover strategies for field teams to convey program value whilst also being mindful of selling and/or medical language
- Examine how field teams work across the organization, including interactions and rules of engagement for FRMs and the importance of being proactive vs. reactive
- Delve into key areas of concern, including script usage, medical reporting boundaries and compensation nuances
- Kristen Butler-Cummings - National Director, Key Account Management & Strategic Advocacy, Pharmacosmos Therapeutics Inc.
Typically dominated by specialty therapeutics, the patient services industry is noticing an uptake in programs for retail therapies as well. Manufacturers must rethink how to operationalize their programs on a different scale to meet these patients’ needs. During this session, uncover the best path forward to serve retail patients and identify the key differences and challenges in your specialty vs. retail programs.
- Erica Devine - Director, Patient Experience and Support Nephrology/Rare, Otsuka
- Meghan Szczech, MBA - Executive Director, Patient Services and Trade, SK Life Science Inc
For the past 6 years Nuvera has captured insights from HCPs and patients related to pharma PSPs through our syndicated PURE Study. As payers continue to increase pressure on pharma, it was important to gain insights into their mindset and anticipated actions that will impact patient access and affordability, particularly as the full implementation of the Inflation Reduction Act comes into focus. Nuvera will share key learnings from these payers and what it means for your patient support programs to ensure your organization is aligned and prepared to address the ongoing and new challenges. We will also share 2024 “Best-in-Class” Pharma Patient Support Programs based on ratings from over 2,000 HCPs.
- Derek Cothran - Principal, Nuvera Life Science Consulting
- Edward Gajewski - Principal, Nuvera Life Science Consulting
Data Privacy regulations are a compliance minefield for patient support programs. During this session, unravel the legal complexities and unpack the evolving regulatory landscape to ensure that your organization is operating compliantly.
- Deep dive into the varying state laws surrounding data privacy and e-prescriptions, and understand their effect on patient consent/signatures/HIPAA
- Benchmark on best practices in building a compliant website, including the types of information that you are (and are not) allowed to collect and the standard disclaimers that need to be incorporated
- Uncover the patient health information that is necessary for your program, and the controls that should be instated surrounding this data
Kick-start your afternoon with a personal development summit, hearing real-life experiences of colleagues’ successes, challenges, and individual experiences in creating a more inclusive culture within the patient support sector.
- Understand the correlation between health and financial literacy and patient adherence and engagement
- Benchmark with colleagues on how to revitalize your patient education material to address cultural misconception and/or mistrust and raise awareness surrounding clinical trials
- Brainstorm innovative solutions that manufactures can utilize to better partner with patient advocacy groups
- Emily Gibb - Vice President, Head of Novartis Patient Support Cardiovascular, Renal, and Metabolic, Novartis
Rare disease patients face a multitude of challenges, two of which include limited treatment options and a lack of dedicated and holistic support. This session tackles both, empowering industry leaders to create high-touch patient support programs to truly optimize patient outcomes.
- Learn innovative strategies to connect with and educate rare disease patients about available resources, even in the absence of approved therapies
- Explore effective methods for establishing trust and fostering long-term relationships. Discover partnerships, such as with patient advocacy organizations, to collaborate with
- Strategize on building programs that specifically cater to the needs of rare disease populations
- Liz Turner - Vice President, Global Market Access, Mirum Pharmaceuticals, Inc.
When building out your suite of services, you want to ensure that they are here to stay. In order to do so, your program needs to be able to pivot and be flexible with the everchanging marketplace.
- Uncover the best practices in monitoring your program, and specifically your hub, throughout its lifecycle
- Discuss the harms of remaining static, the benefits that both patients and providers derive from an agile program and how smooth communication can help you achieve that
- Danny Sigurdson - CEO, Courier Health
- Suzanne Marinakos - Director, Patient Services Operations, Novo Nordisk